Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000711377-10-000025)

Filing Details

Accession Number:: 0000711377-10-000025
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-10-05 10:47:47
Reporting Period:: 2010-10-01

Filing Date:: 2010-10-05
Accepted Time:: 2010-10-05 10:47:47
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
711377	Neogen Corp	NEOG	In Vitro & In Vivo Diagnostic Substances (2835)	382367843

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1187316	T Richard Crowder			Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-10-01	500	$32.75	500	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Common Stock Option (Right to buy)	$20.33		2019-10-10	2,500	2,500	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2019-10-10	2,500	2,500	Direct

Footnotes

The option was granted 10/10/09 as a NQ option that will become exercisable 33% yearly thereafter.